Hospitals file amended US antitrust claims in case over Revlimid
MLex Summary: Hospitals filed an amended US antitrust complaint accusing Bristol-Myers Squibb, Natco Pharma, Teva Pharmaceuticals, and Dr. Reddy’s Laboratories of illegally closing off generic competition to branded Revlimid. See document below. ...To view the full article, register now.
Already a subscriber? Click here to view full article